4//SEC Filing
Claiborne Cary J 4
Accession 0001213900-22-009419
CIK 0001513525other
Filed
Feb 24, 7:00 PM ET
Accepted
Feb 25, 2:54 PM ET
Size
12.7 KB
Accession
0001213900-22-009419
Insider Transaction Report
Form 4
Claiborne Cary J
DirectorChief Executive Officer
Transactions
- Award
Employee Stock Option
2022-02-23+6,667→ 6,667 totalExercise: $2.00From: 2022-03-23Exp: 2032-02-22→ Common Stock (6,667 underlying)
Footnotes (1)
- [F1]The option vests pro rata on a monthly basis over 36 months commencing March 23, 2022.
Issuer
ADIAL PHARMACEUTICALS, INC.
CIK 0001513525
Entity typeother
Related Parties
1- filerCIK 0001370930
Filing Metadata
- Form type
- 4
- Filed
- Feb 24, 7:00 PM ET
- Accepted
- Feb 25, 2:54 PM ET
- Size
- 12.7 KB